Articles

Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas

Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine;Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
Division of Virology and Immunology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo
Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
Vol. 103 No. 1 (2018): January, 2018 https://doi.org/10.3324/haematol.2017.177279